FDA Panel Rejects Brainstorm Cell Therapeutics ALS Treatment

A U.S. Food and Drug Administration advisory committee voted against a treatment from BrainStorm Cell Therapeutics for amyotrophic lateral sclerosis, or ALS.

Related Keywords

Liz Essley Whyte ,Drug Administration ,Liz Essley ,Brainstorm Cell Therapeutics ,Article Normal ,Biotechnology ,Pharmaceuticals ,Regulation Government Policy ,New Products Services ,Product Service Approvals ,Corporate Industrial News ,Products Services ,Health ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Brainstorm Cell Therapeutics Inc ,Bcli ,Regulation ,Government Policy ,New Products ,Services ,Product ,Service Approvals ,Corporate ,Industrial News ,Products ,